Diagnostic terminology for urinary cytology reports including the new subcategories 'atypical urothelial cells of undetermined significance' (AUC-US) and 'cannot exclude high grade' (AUC-H)

Objective We studied whether atypical, non‐superficial urothelial cells (AUC) could be separated into new subcategories including AUC ‘of undetermined significance’ (AUC‐US) and ‘cannot exclude high grade’’ (AUC‐H) in order to help to standardize urine cytopathology reports, as it is widely accepted...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cytopathology (Oxford) 2014-02, Vol.25 (1), p.27-38
Hauptverfasser: Piaton, E., Decaussin-Petrucci, M., Mege-Lechevallier, F., Advenier, A.-S., Devonec, M., Ruffion, A.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 38
container_issue 1
container_start_page 27
container_title Cytopathology (Oxford)
container_volume 25
creator Piaton, E.
Decaussin-Petrucci, M.
Mege-Lechevallier, F.
Advenier, A.-S.
Devonec, M.
Ruffion, A.
description Objective We studied whether atypical, non‐superficial urothelial cells (AUC) could be separated into new subcategories including AUC ‘of undetermined significance’ (AUC‐US) and ‘cannot exclude high grade’’ (AUC‐H) in order to help to standardize urine cytopathology reports, as it is widely accepted in the Bethesda system for gynaecological cytopathology. Methods We investigated whether AUC‐US and AUC‐H, defined by distinctive cytological criteria, might be separated with statistical significance according to actual diagnosis and follow‐up data. A series of 534 cyto‐histological comparisons taken in 139 patients, including 221 AUC at various steps of their clinical history was studied. There were 513 (96.1%) postcystoscopy and 469 (87.8%) ThinPrep® liquid‐based specimens (95.9% and 89.1% of AUC cases, respectively). Patients viewed between 1999 and 2011 had histological control in a 0‐ to 6‐months delay and were followed‐up during an additional 5.9 ± 9.2 (0‐ to 56‐) months period. Results The 221 AUC represented 0.8–2% of the specimens viewed during the study period. Among AUC‐H cases, 70 out of 185 (37.8%) matched with high‐grade lesions, compared with 3 of 38 (8.3%) of AUC‐US cases (P = 0.0003). Conservatively treated patients with AUC‐H more frequently developed high‐grade lesions than those with AUC‐US (54.1% versus 16.7%, P = 0.0007) with a 17.6‐months mean delay. Nuclear hyperchromasia, a nuclear to cytoplasm (N/C) ratio > 0.7 and the combination of both were the more informative diagnostic criteria, all with P 
doi_str_mv 10.1111/cyt.12050
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1490752310</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1490752310</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3630-9f7d3eab262659966f2a3a3972ffb5bcf78cb792dc24e847a17e2c7e0e3142703</originalsourceid><addsrcrecordid>eNp1kc9y0zAQhzUMDA2FAy_A6Jbm4FZ_bCs-dgI0DAEONAOcNLK8cgSOFCR7Wj8c74aCm97QRZqdb78d7Q-h15Rc0nSu9NhfUkYK8gTNKC-LjHHCn6IZqYoyKwoiztCLGH8SQlnF-HN0xnheUkGrGfrz1qrW-dhbjXsIe-t859sRGx_wEKxTYcRJPxUDHHzoI7ZOd0NjXYv7HWAHdzgOtVY9tD5YiHiu-vFgteqSwieks-mpoesi9gYProFpFDQ42tZZk1inYY4vrrerbPt1gZVr8DwVne8x3B-nAd7ZdofboJoTuF68RM-M6iK8erjP0fb9u9vVOtt8ufmwut5kmpecZJURDQdVs5KVRVWVpWGKK14JZkxd1NqIpa5FxRrNcljmQlEBTAsgwGnOBOHn6GLyHoL_PUDs5d7G44eUAz9ESfOKiIJxekQXE6qDjzGAkYdg92mNkhJ5TEumdcp_aSX2zYN2qPfQPJKneBJwNQF3toPx_ya5-nF7UmZTh4093D92qPBLloKLQn77fCOX60_fN_mykh_5X-xzsFc</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1490752310</pqid></control><display><type>article</type><title>Diagnostic terminology for urinary cytology reports including the new subcategories 'atypical urothelial cells of undetermined significance' (AUC-US) and 'cannot exclude high grade' (AUC-H)</title><source>MEDLINE</source><source>Wiley Online Library All Journals</source><creator>Piaton, E. ; Decaussin-Petrucci, M. ; Mege-Lechevallier, F. ; Advenier, A.-S. ; Devonec, M. ; Ruffion, A.</creator><creatorcontrib>Piaton, E. ; Decaussin-Petrucci, M. ; Mege-Lechevallier, F. ; Advenier, A.-S. ; Devonec, M. ; Ruffion, A.</creatorcontrib><description>Objective We studied whether atypical, non‐superficial urothelial cells (AUC) could be separated into new subcategories including AUC ‘of undetermined significance’ (AUC‐US) and ‘cannot exclude high grade’’ (AUC‐H) in order to help to standardize urine cytopathology reports, as it is widely accepted in the Bethesda system for gynaecological cytopathology. Methods We investigated whether AUC‐US and AUC‐H, defined by distinctive cytological criteria, might be separated with statistical significance according to actual diagnosis and follow‐up data. A series of 534 cyto‐histological comparisons taken in 139 patients, including 221 AUC at various steps of their clinical history was studied. There were 513 (96.1%) postcystoscopy and 469 (87.8%) ThinPrep® liquid‐based specimens (95.9% and 89.1% of AUC cases, respectively). Patients viewed between 1999 and 2011 had histological control in a 0‐ to 6‐months delay and were followed‐up during an additional 5.9 ± 9.2 (0‐ to 56‐) months period. Results The 221 AUC represented 0.8–2% of the specimens viewed during the study period. Among AUC‐H cases, 70 out of 185 (37.8%) matched with high‐grade lesions, compared with 3 of 38 (8.3%) of AUC‐US cases (P = 0.0003). Conservatively treated patients with AUC‐H more frequently developed high‐grade lesions than those with AUC‐US (54.1% versus 16.7%, P = 0.0007) with a 17.6‐months mean delay. Nuclear hyperchromasia, a nuclear to cytoplasm (N/C) ratio &gt; 0.7 and the combination of both were the more informative diagnostic criteria, all with P &lt; 0.01. Conclusion We conclude that the new subcategories could help to standardize urine cytopathology reports and contribute to the patient's management, provided it is validated by multicentric studies.</description><identifier>ISSN: 0956-5507</identifier><identifier>EISSN: 1365-2303</identifier><identifier>DOI: 10.1111/cyt.12050</identifier><identifier>PMID: 23461719</identifier><language>eng</language><publisher>England: Blackwell Publishing Ltd</publisher><subject>Aged ; Aged, 80 and over ; atypical urothelial cells ; bladder cancer ; Cytodiagnosis ; Epithelial Cells - pathology ; Female ; high grade ; Humans ; Male ; Middle Aged ; Neoplasm Grading ; reporting ; terminology ; Terminology as Topic ; Urinary Bladder Neoplasms - diagnosis ; Urinary Bladder Neoplasms - pathology ; urinary cytology ; Uterine Cervical Neoplasms - diagnosis ; Uterine Cervical Neoplasms - pathology</subject><ispartof>Cytopathology (Oxford), 2014-02, Vol.25 (1), p.27-38</ispartof><rights>2013 John Wiley &amp; Sons Ltd</rights><rights>2013 John Wiley &amp; Sons Ltd.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3630-9f7d3eab262659966f2a3a3972ffb5bcf78cb792dc24e847a17e2c7e0e3142703</citedby><cites>FETCH-LOGICAL-c3630-9f7d3eab262659966f2a3a3972ffb5bcf78cb792dc24e847a17e2c7e0e3142703</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fcyt.12050$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fcyt.12050$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>315,782,786,1419,27931,27932,45581,45582</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23461719$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Piaton, E.</creatorcontrib><creatorcontrib>Decaussin-Petrucci, M.</creatorcontrib><creatorcontrib>Mege-Lechevallier, F.</creatorcontrib><creatorcontrib>Advenier, A.-S.</creatorcontrib><creatorcontrib>Devonec, M.</creatorcontrib><creatorcontrib>Ruffion, A.</creatorcontrib><title>Diagnostic terminology for urinary cytology reports including the new subcategories 'atypical urothelial cells of undetermined significance' (AUC-US) and 'cannot exclude high grade' (AUC-H)</title><title>Cytopathology (Oxford)</title><addtitle>Cytopathology</addtitle><description>Objective We studied whether atypical, non‐superficial urothelial cells (AUC) could be separated into new subcategories including AUC ‘of undetermined significance’ (AUC‐US) and ‘cannot exclude high grade’’ (AUC‐H) in order to help to standardize urine cytopathology reports, as it is widely accepted in the Bethesda system for gynaecological cytopathology. Methods We investigated whether AUC‐US and AUC‐H, defined by distinctive cytological criteria, might be separated with statistical significance according to actual diagnosis and follow‐up data. A series of 534 cyto‐histological comparisons taken in 139 patients, including 221 AUC at various steps of their clinical history was studied. There were 513 (96.1%) postcystoscopy and 469 (87.8%) ThinPrep® liquid‐based specimens (95.9% and 89.1% of AUC cases, respectively). Patients viewed between 1999 and 2011 had histological control in a 0‐ to 6‐months delay and were followed‐up during an additional 5.9 ± 9.2 (0‐ to 56‐) months period. Results The 221 AUC represented 0.8–2% of the specimens viewed during the study period. Among AUC‐H cases, 70 out of 185 (37.8%) matched with high‐grade lesions, compared with 3 of 38 (8.3%) of AUC‐US cases (P = 0.0003). Conservatively treated patients with AUC‐H more frequently developed high‐grade lesions than those with AUC‐US (54.1% versus 16.7%, P = 0.0007) with a 17.6‐months mean delay. Nuclear hyperchromasia, a nuclear to cytoplasm (N/C) ratio &gt; 0.7 and the combination of both were the more informative diagnostic criteria, all with P &lt; 0.01. Conclusion We conclude that the new subcategories could help to standardize urine cytopathology reports and contribute to the patient's management, provided it is validated by multicentric studies.</description><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>atypical urothelial cells</subject><subject>bladder cancer</subject><subject>Cytodiagnosis</subject><subject>Epithelial Cells - pathology</subject><subject>Female</subject><subject>high grade</subject><subject>Humans</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Neoplasm Grading</subject><subject>reporting</subject><subject>terminology</subject><subject>Terminology as Topic</subject><subject>Urinary Bladder Neoplasms - diagnosis</subject><subject>Urinary Bladder Neoplasms - pathology</subject><subject>urinary cytology</subject><subject>Uterine Cervical Neoplasms - diagnosis</subject><subject>Uterine Cervical Neoplasms - pathology</subject><issn>0956-5507</issn><issn>1365-2303</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kc9y0zAQhzUMDA2FAy_A6Jbm4FZ_bCs-dgI0DAEONAOcNLK8cgSOFCR7Wj8c74aCm97QRZqdb78d7Q-h15Rc0nSu9NhfUkYK8gTNKC-LjHHCn6IZqYoyKwoiztCLGH8SQlnF-HN0xnheUkGrGfrz1qrW-dhbjXsIe-t859sRGx_wEKxTYcRJPxUDHHzoI7ZOd0NjXYv7HWAHdzgOtVY9tD5YiHiu-vFgteqSwieks-mpoesi9gYProFpFDQ42tZZk1inYY4vrrerbPt1gZVr8DwVne8x3B-nAd7ZdofboJoTuF68RM-M6iK8erjP0fb9u9vVOtt8ufmwut5kmpecZJURDQdVs5KVRVWVpWGKK14JZkxd1NqIpa5FxRrNcljmQlEBTAsgwGnOBOHn6GLyHoL_PUDs5d7G44eUAz9ESfOKiIJxekQXE6qDjzGAkYdg92mNkhJ5TEumdcp_aSX2zYN2qPfQPJKneBJwNQF3toPx_ya5-nF7UmZTh4093D92qPBLloKLQn77fCOX60_fN_mykh_5X-xzsFc</recordid><startdate>201402</startdate><enddate>201402</enddate><creator>Piaton, E.</creator><creator>Decaussin-Petrucci, M.</creator><creator>Mege-Lechevallier, F.</creator><creator>Advenier, A.-S.</creator><creator>Devonec, M.</creator><creator>Ruffion, A.</creator><general>Blackwell Publishing Ltd</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201402</creationdate><title>Diagnostic terminology for urinary cytology reports including the new subcategories 'atypical urothelial cells of undetermined significance' (AUC-US) and 'cannot exclude high grade' (AUC-H)</title><author>Piaton, E. ; Decaussin-Petrucci, M. ; Mege-Lechevallier, F. ; Advenier, A.-S. ; Devonec, M. ; Ruffion, A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3630-9f7d3eab262659966f2a3a3972ffb5bcf78cb792dc24e847a17e2c7e0e3142703</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>atypical urothelial cells</topic><topic>bladder cancer</topic><topic>Cytodiagnosis</topic><topic>Epithelial Cells - pathology</topic><topic>Female</topic><topic>high grade</topic><topic>Humans</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Neoplasm Grading</topic><topic>reporting</topic><topic>terminology</topic><topic>Terminology as Topic</topic><topic>Urinary Bladder Neoplasms - diagnosis</topic><topic>Urinary Bladder Neoplasms - pathology</topic><topic>urinary cytology</topic><topic>Uterine Cervical Neoplasms - diagnosis</topic><topic>Uterine Cervical Neoplasms - pathology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Piaton, E.</creatorcontrib><creatorcontrib>Decaussin-Petrucci, M.</creatorcontrib><creatorcontrib>Mege-Lechevallier, F.</creatorcontrib><creatorcontrib>Advenier, A.-S.</creatorcontrib><creatorcontrib>Devonec, M.</creatorcontrib><creatorcontrib>Ruffion, A.</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Cytopathology (Oxford)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Piaton, E.</au><au>Decaussin-Petrucci, M.</au><au>Mege-Lechevallier, F.</au><au>Advenier, A.-S.</au><au>Devonec, M.</au><au>Ruffion, A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Diagnostic terminology for urinary cytology reports including the new subcategories 'atypical urothelial cells of undetermined significance' (AUC-US) and 'cannot exclude high grade' (AUC-H)</atitle><jtitle>Cytopathology (Oxford)</jtitle><addtitle>Cytopathology</addtitle><date>2014-02</date><risdate>2014</risdate><volume>25</volume><issue>1</issue><spage>27</spage><epage>38</epage><pages>27-38</pages><issn>0956-5507</issn><eissn>1365-2303</eissn><abstract>Objective We studied whether atypical, non‐superficial urothelial cells (AUC) could be separated into new subcategories including AUC ‘of undetermined significance’ (AUC‐US) and ‘cannot exclude high grade’’ (AUC‐H) in order to help to standardize urine cytopathology reports, as it is widely accepted in the Bethesda system for gynaecological cytopathology. Methods We investigated whether AUC‐US and AUC‐H, defined by distinctive cytological criteria, might be separated with statistical significance according to actual diagnosis and follow‐up data. A series of 534 cyto‐histological comparisons taken in 139 patients, including 221 AUC at various steps of their clinical history was studied. There were 513 (96.1%) postcystoscopy and 469 (87.8%) ThinPrep® liquid‐based specimens (95.9% and 89.1% of AUC cases, respectively). Patients viewed between 1999 and 2011 had histological control in a 0‐ to 6‐months delay and were followed‐up during an additional 5.9 ± 9.2 (0‐ to 56‐) months period. Results The 221 AUC represented 0.8–2% of the specimens viewed during the study period. Among AUC‐H cases, 70 out of 185 (37.8%) matched with high‐grade lesions, compared with 3 of 38 (8.3%) of AUC‐US cases (P = 0.0003). Conservatively treated patients with AUC‐H more frequently developed high‐grade lesions than those with AUC‐US (54.1% versus 16.7%, P = 0.0007) with a 17.6‐months mean delay. Nuclear hyperchromasia, a nuclear to cytoplasm (N/C) ratio &gt; 0.7 and the combination of both were the more informative diagnostic criteria, all with P &lt; 0.01. Conclusion We conclude that the new subcategories could help to standardize urine cytopathology reports and contribute to the patient's management, provided it is validated by multicentric studies.</abstract><cop>England</cop><pub>Blackwell Publishing Ltd</pub><pmid>23461719</pmid><doi>10.1111/cyt.12050</doi><tpages>12</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0956-5507
ispartof Cytopathology (Oxford), 2014-02, Vol.25 (1), p.27-38
issn 0956-5507
1365-2303
language eng
recordid cdi_proquest_miscellaneous_1490752310
source MEDLINE; Wiley Online Library All Journals
subjects Aged
Aged, 80 and over
atypical urothelial cells
bladder cancer
Cytodiagnosis
Epithelial Cells - pathology
Female
high grade
Humans
Male
Middle Aged
Neoplasm Grading
reporting
terminology
Terminology as Topic
Urinary Bladder Neoplasms - diagnosis
Urinary Bladder Neoplasms - pathology
urinary cytology
Uterine Cervical Neoplasms - diagnosis
Uterine Cervical Neoplasms - pathology
title Diagnostic terminology for urinary cytology reports including the new subcategories 'atypical urothelial cells of undetermined significance' (AUC-US) and 'cannot exclude high grade' (AUC-H)
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-05T02%3A33%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Diagnostic%20terminology%20for%20urinary%20cytology%20reports%20including%20the%20new%20subcategories%20'atypical%20urothelial%20cells%20of%20undetermined%20significance'%20(AUC-US)%20and%20'cannot%20exclude%20high%20grade'%20(AUC-H)&rft.jtitle=Cytopathology%20(Oxford)&rft.au=Piaton,%20E.&rft.date=2014-02&rft.volume=25&rft.issue=1&rft.spage=27&rft.epage=38&rft.pages=27-38&rft.issn=0956-5507&rft.eissn=1365-2303&rft_id=info:doi/10.1111/cyt.12050&rft_dat=%3Cproquest_cross%3E1490752310%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1490752310&rft_id=info:pmid/23461719&rfr_iscdi=true